Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients
暂无分享,去创建一个
I. Paulsen | I. Seppelt | A. Holmes | J. Iredell | S. Partridge | S. Tetu | L. Thomas | A. Ginn | V. Nayyar | Mitchell Brown | C. Venturini | M. Kabir | H. K. Gamage | Belinda Roychoudhry